تحليلات المنتج الاختيارية
بإذنك، نستخدم تحليلات محدودة تراعي الخصوصية لفهم مسارات البحث الفعالة. لا نستخدم أدوات تتبع إعلانية أو تسجيل الجلسات. يمكنك تغيير هذا الخيار في التفضيلات. اقرأ سياسة الخصوصية.
Merck & Co., Inc.'s published Hold conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $370.9B | |
|---|---|---|
| Revenue (ttm) | 66.6B | |
| Net income (ttm) | 3.2B | |
| EPS (ttm) | $1.27 | |
| Shares out | 2.5B | |
| P/E (trailing) | 110.8x | |
| P/E (forward) | 15.7x | |
| Dividend | $3.40 (2.42%) | |
| Volume | 6,404,220 | |
| Beta | 0.22 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $48.70B | $59.28B | $60.12B | $64.17B | $65.01B | +7.5% |
| Gross profit | $35.08B | $41.87B | $43.99B | $48.98B | $46.73B | +7.4% |
| Operating income | $14.69B | $17.41B | $3.04B | $21.21B | $22.42B | +11.2% |
| Net income | $13.05B | $14.52B | $365.0M | $17.12B | $18.25B | +8.8% |
| EPS (diluted) | $5.14 | $5.71 | $0.14 | $6.74 | $7.28 | +9.1% |
| EBITDA | $17.90B | $21.32B | $6.91B | $25.71B | $28.26B | +12.1% |
| R&D | $12.25B | $13.55B | $30.53B | $17.94B | $15.79B | +6.6% |
| SG&A | $9.63B | $10.04B | $10.50B | $10.82B | $10.73B | +2.7% |
Recent company headlines from major financial publishers.
Revenue recovery continues, margins normalize and per-share results receive modest support from a lower share count. Later growth remains measured rather than accelerating.
Upside persists if growth and margins last beyond the rebound. It fades if stronger results require more investment or debt than operating cash can fund.
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 4.6% | $176 | $195 | $223 | $268 | $352 |
| 5.6% | $146 | $156 | $169 | $187 | $214 |
| 6.6% | $127 | $133 | $141 | $150 | $163 |
| 7.6% | $114 | $118 | $122 | $128 | $135 |
| 8.6% | $104 | $107 | $110 | $114 | $118 |
Upcoming earnings date and setup when available.
التصنيف الذي حملته نسخة البحث المنشورة في كل شهر. يقارن التصنيف السعر في تاريخ التحليل بالقيمة العادلة، وليس سجلاً لمدى صحة التقدير.
| السنة | يناير | فبراير | مارس | أبريل | مايو | يونيو | يوليو | أغسطس | سبتمبر | أكتوبر | نوفمبر | ديسمبر |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
